Comparing Aflibercept Monotherapy With Aflibercept Plus Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy PLANET or Asteroid?

被引：3
|
作者：
Browning, David J. [1 ]
机构：
[1] Charlotte Eye Ear Nose & Throat Associates, 6035 Fairview Rd, Charlotte, NC 28210 USA
来源：
JAMA OPHTHALMOLOGY | 2018年 / 136卷 / 07期
关键词：
VEGF TRAP; MACULAR DEGENERATION; RANIBIZUMAB; CONBERCEPT; EFFICACY; SAFETY;
D O I：
10.1001/jamaophthalmol.2018.1799
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：794 / 795
页数：2
相关论文
共 50 条
  • [11] Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept
    Vadala, Maria
    Castellucci, Massimo
    Guarrasi, Giulia
    Cillino, Giovanni
    Bonfiglio, Vincenza Maria Elena
    Casuccio, Alessandra
    Cillino, Salvatore
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (02) : 601 - 610
  • [12] Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy
    Mary Ho
    Donald C. F. Woo
    Vesta C. K. Chan
    Alvin L. Young
    Marten E. Brelen
    Scientific Reports, 6
  • [13] Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy
    Ho, Mary
    Woo, Donald C. F.
    Chan, Vesta C. K.
    Young, Alvin L.
    Brelen, Marten E.
    SCIENTIFIC REPORTS, 2016, 6
  • [14] CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Kikushima, Wataru
    Kume, Atsuki
    Iijima, Hiroyuki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1866 - 1872
  • [15] Aflibercept for the Treatment of Polypoidal Choroidal Vasculopathy
    Shah, Sabah
    Zhou, Di
    Slakter, Jason S.
    Yannuzzi, Lawrence A.
    Barbazetto, Irene A.
    Freund, K. Bailey
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [16] Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy
    Yoneda, Ai
    Wakiyama, Harumi
    Kurihara, Junko
    Kitaoka, Takashi
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (06) : 1473 - 1479
  • [17] Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy
    Wataru Kikushima
    Yoichi Sakurada
    Atsushi Sugiyama
    Naohiko Tanabe
    Atsuki Kume
    Hiroyuki Iijima
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 311 - 316
  • [18] Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Kume, Atsuki
    Iijima, Hiroyuki
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (02) : 311 - 316
  • [19] Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
    Ma, I-Hsin
    Hsia, Yun
    Hsieh, Yi-Ting
    Ho, Tzyy-Chang
    Lai, Tso-Ting
    Yang, Chung-May
    Yang, Chang-Hao
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [20] Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
    I-Hsin Ma
    Yun Hsia
    Yi-Ting Hsieh
    Tzyy-Chang Ho
    Tso-Ting Lai
    Chung-May Yang
    Chang-Hao Yang
    Scientific Reports, 11
12345